Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema

By  

International Archives of Allergy and Immunology, Vol. 166, Iss. 4, 2015-04 ,pp. : 259-266

Karger

Access to resources Recommend Favorite

Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema

By  

Cytogenetic and Genome Research, Vol. 121, Iss. 3-4, 2008-08 ,pp. : 181-188

Karger

Access to resources Recommend Favorite

Pharmacokinetics of plasma‐derived C1‐esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1552-1561

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hereditary angioedema with normal C1‐INH with versus without specific F12 gene mutations

By  

ALLERGY, Vol. 70, Iss. 8, 2015-08 ,pp. : 1004-1012

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of on‐demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiency

By  

ALLERGY, Vol. 70, Iss. 12, 2015-12 ,pp. : 1553-1558

John Wiley & Sons Inc

Access to resources Recommend Favorite